Keeping a close eye on implants that are opened and not used is one way OR leaders can track practices that add significantly to costs. But what about blood products? Blood taken to the OR and not used also can be costly.
Welcome to OR Manager, your source of information and insight into the clinical and business management of the surgical suite. This article is only available to OR Manager subscribers. To read this article, and gain access to all OR Manager resources, please log in below:
Username
Password
Explore Subscription Options
Please contact our Customer Service Team if you are unable to log in at clientservices@accessintel.com or 1-888-707-5814.
Artificial intelligence (AI) has made inroads into nearly every area…
Find out more
It is with great excitement that we welcome you to…
As you dive into this year's OR Manager Conference, here…